Aicaigou LogoB2B Wiki

Peptide Hydrogel

Updated: 2026-09-16

Overview

Peptide hydrogel is a class of soft materials formed by the self-assembly of short peptide sequences under physiological conditions. These hydrogels mimic natural extracellular matrices, making them ideal for biomedical applications. The gelation process is often triggered by changes in pH, temperature, or ionic strength. The material's modular design allows customization of mechanical properties, degradation rates, and bioactive motifs. This adaptability has led to its adoption in research labs and clinical trials, particularly for regenerative medicine and controlled drug release systems.

Physical and Chemical Properties

Peptide hydrogels exhibit viscoelastic behavior with storage moduli typically ranging from 0.1-20 kPa, adjustable by peptide concentration or crosslinking. They maintain >90% water content while retaining structural integrity, resembling natural tissues' hydration levels. The peptides' amino acid sequence determines secondary structures (β-sheets, α-helices) that drive self-assembly. Most formulations are stable at physiological pH (7.4) but may dissolve under extreme acidic/basic conditions. Degradation occurs via proteolytic enzymes or hydrolysis over days to months.

Main Applications

In drug delivery, peptide hydrogels provide sustained release of therapeutics like growth factors or anticancer drugs, with release kinetics controlled by mesh size and degradation. Their injectability enables minimally invasive administration. Tissue engineering utilizes these gels as 3D scaffolds for stem cell differentiation and organoid growth. Specific peptide motifs (e.g., RGD) enhance cell adhesion. Emerging uses include diabetic wound healing dressings and neural regeneration matrices due to their axon-guiding nanofibrous structures.

Safety and Storage

Pre-formed hydrogels are generally sterile-filterable or autoclavable, while peptide powders require aseptic handling. Long-term storage at 4°C preserves stability; freeze-thaw cycles should be avoided to prevent fibril disruption. Although inherently biocompatible, endotoxin levels must be <0.25 EU/mL for implantable applications. In vitro cytotoxicity testing (ISO 10993-5) is recommended for new formulations. Users should wear PPE when handling dry peptides to prevent respiratory irritation.

B2B Procurement Guide

Industrial buyers should verify: 1) cGMP compliance for clinical-grade material, 2) batch-to-batch consistency in rheological properties, and 3) supplier capabilities for custom sequence design. Bulk orders (100g+) may qualify for 15-30% discounts. Key specifications include gelation time (minutes to hours), minimum gelation concentration (typically 0.1-2% w/v), and endotoxin certification. Consider suppliers offering technical support for formulation optimization and sterilization validation.

Related Manufacturers